Laden...
Having trouble viewing this email? View it as a Web page. You are receiving this message because you are subscribed to News Releases for National Institutes of Health (NIH). Phase 3 trial of Novavax investigational COVID-19 vaccine opens 12/28/2020 09:15 AM ESTNIH- and BARDA-funded trial will enroll up to 30,000 volunteers.
|
Laden...
Laden...
© 2024